← Neuronetics, Inc.
| Annual Trend | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net loss | ($16.1m) | ($24.1m) | ($29.0m) | ($27.5m) | ($31.2m) | ($37.2m) | ($30.2m) | ($43.7m) | ($39.1m) | — | |
| Depreciation and amortization | $596k | $882k | $1.1m | $941k | $1.1m | $1.6m | $2.0m | $2.1m | $3.5m | $3.3m | |
| Share-based compensation | $496k | $1.7m | $3.4m | $4.4m | $7.9m | $8.7m | $7.3m | $5.6m | $6.8m | $7.1m | |
| Capitalized software impairment | — | — | — | — | — | — | — | $4.0m | — | — | |
| Inventory impairment | — | — | — | — | — | — | $1.9m | $626k | $388k | — | |
| Accounts receivable, net | ($690k) | ($1.4m) | ($950k) | ($597k) | ($3.1m) | ($6.3m) | ($8.8m) | ($3.7m) | $3.5m | $7.2m | |
| Reduction of accounts receivable in current and long-term notes receivable | — | — | — | — | $2.5m | $432k | $6.5m | $606k | — | — | |
| Inventory | ($1.1m) | ($435k) | ($306k) | ($945k) | ($3.4m) | ($2.6m) | ($1.1m) | $3.1m | ($395k) | ($1.0m) | |
| Transfer of inventory to property and equipment | $296k | $365k | $37k | — | $601k | $250k | $210k | $92k | $106k | — | |
| Accounts payable | $788k | $606k | $299k | ($1.1m) | $276k | ($2.0m) | $2.0m | ($2.0m) | ($1.8m) | $1.4m | |
| Purchases of property and equipment and capitalized software in accounts payable and accrued expenses | $45k | $263k | $377k | $208k | $273k | $103k | $239k | $13k | $83k | ($779k) | |
| Accrued expenses | $1.4m | ($52k) | $1.5m | ($1.7m) | $910k | $6.6m | ($2.2m) | ($2.1m) | ($502k) | $289k | |
| Deferred revenue | $2.9m | ($49k) | $138k | ($573k) | $215k | ($1.2m) | ($989k) | ($843k) | ($175k) | — | |
| Prepaid expenses and other assets | ($175k) | ($237k) | ($565k) | ($641k) | $62k | $786k | ($2.8m) | ($1.2m) | $4.7m | — | |
| Other liabilities | — | — | — | — | — | — | — | ($66k) | $257k | — | |
| Net Cash used in Operating activities | ($11.1m) |
($20.6m)
-84.77%
|
($30.5m)
-48.04%
|
($28.4m)
+6.86%
|
($28.0m)
+1.43%
|
($30.7m)
-9.85%
|
($32.0m)
-4.23%
|
($31.0m)
+3.25%
|
($20.4m)
+34.27%
|
($12.8m)
+37.17%
|
|
| Loss on disposal of property and equipment | $296k | $365k | $37k | — | $601k | $250k | $210k | $28k | $72k | — | |
| Purchases of property and equipment and capitalized software | ($594k) | ($1.0m) | ($813k) | ($730k) | ($2.4m) | ($3.3m) | ($2.4m) | ($1.5m) | ($801k) | ($779k) | |
| Net investments in sales-type leases | — | — | ($2.6m) | ($1.6m) | $324k | $1.1m | $1.2m | $997k | ($31k) | — | |
| Net Cash used in Investing activities | ($594k) | ($1.0m) | ($813k) | ($730k) | ($9.8m) | $6.7m | ($1.3m) | ($2.4m) | ($801k) | ($754k) | |
| Loss on extinguishment of debt | — | — | — | $622k | — | — | — | $4.4m | — | — | |
| Payments of debt issuance costs | ($1.0m) | — | — | ($821k) | — | ($91k) | ($1.1m) | ($2.6m) | ($168k) | — | |
| Proceeds from issuance of long-term debt | — | — | — | $41.4m | — | — | $25.0m | $57.5m | $10.0m | $10.0m | |
| Repayment of long-term debt | — | — | — | ($38.9m) | — | — | ($1.2m) | ($60.0m) | — | — | |
| Payment for debt extinguishment cost | — | — | — | — | — | — | — | ($4.2m) | — | — | |
| Proceeds from the issuance of common stock | — | — | — | — | $81.0m | — | — | — | $29.0m | — | |
| Payments of common stock offering issuance costs | — | ($3.5m) | — | — | ($401k) | — | — | — | ($2.2m) | — | |
| Net Cash provided by (used in) Financing activities | $23.8m |
$97.0m
+306.95%
|
$2.4m
-97.51%
|
$2.4m
-2.11%
|
$83.0m
+3403.84%
|
$207k
-99.75%
|
$22.7m
+10864.73%
|
($6.8m)
-130.00%
|
$35.9m
+626.59%
|
$11.3m
-68.49%
|
|
| Net increase (decrease) in Cash, Cash equivalents and Restricted cash | $12.1m | $75.4m | ($28.9m) | ($26.8m) | $45.2m | ($23.8m) | ($10.7m) | ($40.2m) | $14.7m | — | |
| Cash, Cash equivalents and Restricted cash, Beginning of Period | $29.1m | $104.6m | $75.7m | $49.0m | $94.1m | $70.3m | $59.7m | $19.5m | $34.1m | — | |
| Cash paid for acquisition, net of cash and restricted cash acquired | — | — | — | — | — | — | — | ($2.6m) | — | — | |
| Restricted cash and cash equivalents | — | — | — | — | — | — | — | $1.0m | $6.0m | — | |
| Additional Supplementary Disclosures | |||||||||||
| Additional Supplementary Disclosures | |||||||||||
| Allowance for credit losses | — | — | — | — | $763k | $341k | $390k | $2.1m | $587k | — | |
| Non-cash interest expense | $722k | $839k | $753k | $1.2m | $715k | $709k | $634k | $771k | $824k | — | |
| Prepaid commission expense | — | — | ($4.5m) | ($1.9m) | ($1.9m) | ($1.2m) | ($1.3m) | ($1.1m) | $958k | — | |
| Repayment of notes receivable | — | — | — | — | ($7.5m) | $10.0m | $1.0m | $1.6m | — | — | |
| Repayment of promissory note | — | — | — | — | $7.5m | $10.0m | — | — | ($211k) | — | |
| Repayment of deferred and contingent consideration | — | — | — | — | — | — | — | — | ($500k) | — | |
| Proceeds from issuance of warrants | — | — | — | — | — | — | — | $2.5m | — | — | |
| Distribution to non-controlling interest | — | — | — | — | — | — | — | — | ($94k) | — | |
| Proceeds from exercises of stock options | $35k | $503k | $2.4m | $690k | $2.4m | $298k | $1k | $1k | $13k | — | |
| Cash and cash equivalents | — | — | — | — | — | $70.3m | $59.7m | $18.5m | $28.1m | $21.2m | |
| Cash paid for interest | $2.0m | $2.8m | $2.9m | $3.9m | $3.3m | $3.5m | $4.8m | $6.5m | $7.6m | — |